LARRIALDIETAKO IKERKETA
![Foto de LARRIALDIETAKO IKERKETA](/img/grupo.png)
![Foto de Universidad Peruana Cayetano Heredia](/img/noimage_org.png)
Universidad Peruana Cayetano Heredia
Lima, PerúUniversidad Peruana Cayetano Heredia-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2022
-
Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial
The Lancet Infectious Diseases, Vol. 22, Núm. 3, pp. 329-340